Patients with hidradenitis suppurativa experienced
In two of the largest Phase III trials conducted in hidradenitis suppurativa (HS), Cosentyx® (secukinumab) treatment
Globe Newswire4-02-2023, 06:41
VolitionRx Limited to Webcast Live at 7-03-2023, 04:32